EUVIMEDOpdag EUVIMED
Crossref

Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long‐term adverse outcomes in Crohn's disease

Agnès Fernández-Clotet iD, Ingrid Ordás iD, Maria Carme Masamunt, Berta Caballol, Sonia Rodríguez, Marta Gallego, Rebeca Barastegui, Anny Carolina Saavedra, Julián Panés, Elena Ricart, Jordi Rimola iD

Alimentary Pharmacology & Therapeutics · 2024-06 · 59 (11) · 1435-1445

DOI: 10.1111/apt.17968 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, published online on 2024-04-23. Written by Agnès Fernández-Clotet and 10 co-authors. Institution: IBD Unit, Gastroenterology Department, Hospital Clinic de Barcelona, Barcelona, Spain. Major MEDLINE topics: Crohn Disease, Magnetic Resonance Imaging. Cited 15 times so far (Crossref); 31 references. Funded by: National R & D & I Program and co-financed by the ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Aims Magnetic resonance enterography (MRE) depicts transmural changes in response to biological treatment for Crohn's disease (CD); however, the long‐term prognostic significance of these findings is unknown. The primary objective of this study was to identify findings on MRE 46 weeks after initiating biological treatment that predict adverse long‐term outcomes.

Methods

Patients with CD underwent MRE 46 weeks after initiating biological treatment and were prospectively followed for 2 years. A logistic regression analysis was performed to assess the prognostic value of different radiologic findings for various predefined adverse outcomes.

Results

Of the 89 patients included, 46 (51.7%) had ≥1 adverse outcome during follow‐up: 40 (44.9%) had clinical recurrence; 18 (20.2%) required surgery, 8 (9%) endoscopic balloon dilation, 12 (13.5%) hospitalization and 7 (7.8%) required corticosteroids. In the multivariate analysis, persistence of severe lesions (MaRIA ≥11) in any intestinal segment was associated with an increased risk of surgery [OR 11.6 (1.5–92.4)], of surgery and/or endoscopic balloon dilation [OR 6.3 (1.3–30.2)], and of clinical relapse [OR 4.6 (1.6–13.9)]. Penetrating lesions were associated with surgery [OR 3.4 (1.2–9.9)]. Creeping fat with hospitalization [OR 5.1 (1.1–25.0)] and corticosteroids requirement [OR 16.0 (1.2–210.0)]. The presence of complications (stricturing and/or penetrating lesions) was associated with having ≥1 adverse outcome [OR 3.35 (1.3–8.5)].

Conclusion

MRE findings at week‐46 after initiating biological therapy can predict long‐term adverse outcomes in CD. Therapeutic intervention may be required in patients with persistence of severe inflammatory lesions, CD‐associated complications, or creeping fat.

Subjects

MeSH terms (MEDLINE)

Crohn DiseaseMagnetic Resonance ImagingHumansFemaleMaleAdultProspective StudiesMiddle AgedPrognosisTreatment OutcomeYoung AdultRecurrenceBiological TherapyFollow-Up Studies

Authors and institutions

  • IBD Unit, Gastroenterology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • IBD Unit, Radiology Department, Hospital Clinic de Barcelona, Barcelona, Spain.

ORCID profiles: Agnès Fernández-Clotet, Ingrid Ordás, Jordi Rimola

Funding

  • National R & D & I Program and co-financed by the ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER)

Cite

APA

Fernández-Clotet, A., Ordás, I., Masamunt, M. C., Caballol, B., Rodríguez, S., Gallego, M., Barastegui, R., Saavedra, A. C., Panés, J., Ricart, E., & Rimola, J. (2024). Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long‐term adverse outcomes in Crohn's disease. Alimentary Pharmacology & Therapeutics, 59(11), 1435-1445. https://doi.org/10.1111/apt.17968

Vancouver

Fernández-Clotet A, Ordás I, Masamunt MC, Caballol B, Rodríguez S, Gallego M, et al. Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long‐term adverse outcomes in Crohn's disease. Alimentary Pharmacology & Therapeutics. 2024;59(11):1435-1445. doi:10.1111/apt.17968

BibTeX
@article{FernndezClotet2024,
  author = {Fernández-Clotet, Agnès and Ordás, Ingrid and Masamunt, Maria Carme and Caballol, Berta and Rodríguez, Sonia and Gallego, Marta and Barastegui, Rebeca and Saavedra, Anny Carolina and Panés, Julián and Ricart, Elena and Rimola, Jordi},
  title = {Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long‐term adverse outcomes in Crohn's disease},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2024},
  volume = {59},
  number = {11},
  pages = {1435--1445},
  doi = {10.1111/apt.17968}
}
Start for free →